Clinical Trial Detail

NCT ID NCT01724606
Title Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

breast adenocarcinoma

Therapies

Sorafenib

Age Groups: adult

No variant requirements are available.